Clinical and Experimental Reproductive Medicine

The Korean Society for Reproductive Medicine (대한생식의학회)
권호 표지
DOI QR코드

DOI QR Code

Beneficial effects of oral antioxidant supplementation on semen quality parameters, reproductive hormones, and sperm DNA integrity in men with idiopathic oligoasthenoteratozoospermia

  • Chaymae Rochdi (Maternal-Child and Mental Health Research Laboratory, Faculty of Medicine and Pharmacy, Mohammed First University) ;
  • Meriem Ouadrhiri (Biomedical and Translational Research Laboratory, Faculty of Medicine and Pharmacy of Fez, Sidi Mohammed Benabdellah University) ;
  • Larbi Allai (Laboratory of Sustainable Agriculture Management, Higher School of Technology Sidi Bennour, Chouaib Doukkali University) ;
  • Ibtissam Bellajdel (Medically Assisted Procreation Unit, Central Laboratory, Mohammed VI University Hospital Center) ;
  • Samira Mamri (Medically Assisted Procreation Unit, Central Laboratory, Mohammed VI University Hospital Center) ;
  • Hafsa Taheri (Maternal-Child and Mental Health Research Laboratory, Faculty of Medicine and Pharmacy, Mohammed First University) ;
  • Hanane Saadi (Maternal-Child and Mental Health Research Laboratory, Faculty of Medicine and Pharmacy, Mohammed First University) ;
  • Ahmed Mimouni (Maternal-Child and Mental Health Research Laboratory, Faculty of Medicine and Pharmacy, Mohammed First University) ;
  • Mohammed Choukri (Maternal-Child and Mental Health Research Laboratory, Faculty of Medicine and Pharmacy, Mohammed First University)
  • Received : 2023.09.21
  • Accepted : 2023.11.30
  • Published : 2024.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: Recently, oral antioxidants in combined forms have been used to treat men with idiopathic infertility. This study aimed to evaluate the effects of treatment with vitamin C, vitamin E, selenium, zinc, arginine, L-carnitine, and coenzyme Q10 on sperm quality parameters, DNA integrity, reproductive hormones, and pregnancy rates in men with infertility and idiopathic oligoasthenoteratozoospermia (OAT). Methods: A prospective study was conducted on 420 men with infertility and idiopathic OAT who took an oral supplement of antioxidant SP-Power tablets twice daily for 6 months. Semen quality, reproductive hormones, and the DNA fragmentation index (DFI) were evaluated at baseline and at 3 and 6 months after supplementation, using the World Health Organization 2021 guidelines. Results: No significant difference was observed in volume or the percentage of typical morphology during treatment. A significant improvement in sperm concentration was observed after supplementation (8.67±1.41, 12.17±1.91, and 19.01±0.86 at baseline, 3, and 6 months respectively, p<0.01). The total motility, progressive motility, and total motile sperm count also increased significantly (p<0.01), whereas the DFI decreased after 6 months. There was an increase in normal FSH levels and testosterone levels after 6 months of supplementation of antioxidant SP-Power but these differences were not statistically significant (p=not significant and p=0.06, respectively). Conclusion: Supplementation with SP-Power tablets improved sperm quality parameters, sperm DFI, some reproductive hormones, and pregnancy rates in men with infertility and idiopathic OAT, which could be attributed to the supplement's synergistic antioxidant action. Further studies are needed to determine the effects of supplementation on oxidative stress markers.

Keywords

Acknowledgement

We sincerely thank the Director of Health Innovation for their collaboration in making antioxidant therapy available to our Fertility Center. We would like to thank all colleagues in the assisted human reproduction unit, who authorized and facilitated data collection.

References

  1. Bjorndahl L, Kirkman Brown J; Other Editorial Board Members of the WHO Laboratory Manual for the Examination and Processing of Human Semen. The sixth edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen: ensuring quality and standardization in basic examination of human ejaculates. Fertil Steril 2022;117:246-51. 
  2. Leung AK, Henry MA, Mehta A. Gaps in male infertility health services research. Transl Androl Urol 2018;7(Suppl 3):S303-9. 
  3. Ventimiglia E, Pozzi E, Capogrosso P, Boeri L, Alfano M, Cazzaniga W, et al. Extensive assessment of underlying etiological factors in primary infertile men reduces the proportion of men with idiopathic infertility. Front Endocrinol (Lausanne) 2021;12:801125. 
  4. Bracke A, Peeters K, Punjabi U, Hoogewijs D, Dewilde S. A search for molecular mechanisms underlying male idiopathic infertility. Reprod Biomed Online 2018;36:327-39. 
  5. Dutta S, Majzoub A, Agarwal A. Oxidative stress and sperm function: a systematic review on evaluation and management. Arab J Urol 2019;17:87-97. 
  6. Agarwal A, Sengupta P. Oxidative stress and its association with male infertility. In: Parekattil SJ, Esteves SC, Agarwal A, editors. Male infertility: contemporary clinical approaches, andrology, ART and antioxidants. 2nd ed. Springer; 2020. p. 57-68. 
  7. Bui AD, Sharma R, Henkel R, Agarwal A. Reactive oxygen species impact on sperm DNA and its role in male infertility. Andrologia 2018;50:e13012. 
  8. Bardaweel SK, Gul M, Alzweiri M, Ishaqat A, ALSalamat HA, Bashatwah RM. Reactive oxygen species: the dual role in physiological and pathological conditions of the human body. Eurasian J Med 2018;50:193-201. 
  9. Mironczuk-Chodakowska I, Witkowska AM, Zujko ME. Endogenous non-enzymatic antioxidants in the human body. Adv Med Sci 2018;63:68-78. 
  10. Adwas AA, Elsayed A, Azab AE, Quwaydir FA. Oxidative stress and antioxidant mechanisms in human body. J Appl Biotechnol Bioeng 2019;6:43-7. 
  11. Subramanian V, Ravichandran A, Thiagarajan N, Govindarajan M, Dhandayuthapani S, Suresh S. Seminal reactive oxygen species and total antioxidant capacity: correlations with sperm parameters and impact on male infertility. Clin Exp Reprod Med 2018;45:88-93. 
  12. Ali M, Martinez M, Parekh N. Are antioxidants a viable treatment option for male infertility? Andrologia 2021;53:e13644. 
  13. Szymanski M, Wandtke T, Wasilow K, Andryszczyk M, Janicki R, Domaracki P. Comparison of 3- and 6-month outcomes of combined oral L-carnitine fumarate and acetyl-L-carnitine therapy, included in an antioxidant formulation, in patients with idiopathic infertility. Am J Mens Health 2021;15:15579883211036790. 
  14. Ahmadi S, Bashiri R, Ghadiri-Anari A, Nadjarzadeh A. Antioxidant supplements and semen parameters: an evidence based review. Int J Reprod Biomed 2016;14:729-36. 
  15. Alahmar AT. Effect of vitamin C, vitamin E, zinc, selenium, and coenzyme Q10 in infertile men with idiopathic oligoasthenozoospermia. Int J Infertil Fetal Med 2017;8:45-9. 
  16. Alahmar AT. Coenzyme Q10 improves sperm motility and antioxidant status in infertile men with idiopathic oligoasthenospermia. Clin Exp Reprod Med 2022;49:277-84. 
  17. Majzoub A, Agarwal A. Antioxidant therapy in idiopathic oligoasthenoteratozoospermia. Indian J Urol 2017;33:207-14. 
  18. Rochdi C, Bellajdel I, El Moudane A, El Assri S, Mamri S, Taheri H, et al. Hormonal, clinical, and genetic profile of infertile patients with azoospermia in Morocco. Pan Afr Med J 2023;45:119. 
  19. Chua SC, Yovich SJ, Hinchliffe PM, Yovich JL. How well do semen analysis parameters correlate with sperm DNA fragmentation?: a retrospective study from 2567 semen samples analyzed by the Halosperm test. J Pers Med 2023;13:518. 
  20. Alahmar AT, Calogero AE, Singh R, Cannarella R, Sengupta P, Dutta S. Coenzyme Q10, oxidative stress, and male infertility: a review. Clin Exp Reprod Med 2021;48:97-104. 
  21. Barati E, Nikzad H, Karimian M. Oxidative stress and male infertility: current knowledge of pathophysiology and role of antioxidant therapy in disease management. Cell Mol Life Sci 2020;77:93-113. 
  22. Kobori Y, Ota S, Sato R, Yagi H, Soh S, Arai G, et al. Antioxidant cosupplementation therapy with vitamin C, vitamin E, and coenzyme Q10 in patients with oligoasthenozoospermia. Arch Ital Urol Androl 2014;86:1-4. 
  23. Singh A, Jahan N, Radhakrishnan G, Banerjee BD. To evaluate the efficacy of combination antioxidant therapy on oxidative stress parameters in seminal plasma in the male infertility. J Clin Diagn Res 2016;10:QC14-7. 
  24. Humaidan P, Haahr T, Povlsen BB, Kofod L, Laursen RJ, Alsbjerg B, et al. The combined effect of lifestyle intervention and antioxidant therapy on sperm DNA fragmentation and seminal oxidative stress in IVF patients: a pilot study. Int Braz J Urol 2022;48:131-56. 
  25. Alahmar AT, Sengupta P, Dutta S, Calogero AE. Coenzyme Q10, oxidative stress markers, and sperm DNA damage in men with idiopathic oligoasthenoteratospermia. Clin Exp Reprod Med 2021;48:150-5. 
  26. Alahmar AT. The effect of selenium therapy on semen parameters, antioxidant capacity, and sperm DNA fragmentation in men with idiopathic oligoasthenoteratospermia. Biol Trace Elem Res 2023;201:5671-6. 
  27. Dadgar Z, Shariatzadeh SM, Mehranjani MS, Kheirolahi A. The therapeutic effect of co-administration of pentoxifylline and zinc in men with idiopathic infertility. Ir J Med Sci 2023;192:431-9. 
  28. Nazari L, Salehpour S, Hosseini S, Allameh F, Jahanmardi F, Azizi E, et al. Effect of antioxidant supplementation containing L-carnitine on semen parameters: a prospective interventional study. JBRA Assist Reprod 2021;25:76-80. 
  29. Bahmyari R, Ariafar A, Sayadi M, Hossieni S, Azima S. The effect of daily intake of selenium, vitamin E and folic acid on sperm parameters in males with idiopathic infertility: a single-blind randomized controlled clinical trial. Int J Fertil Steril 2021;15:8-14. 
  30. Matorras R, Perez-Sanz J, Corcostegui B, Perez-Ruiz I, Malaina I, Quevedo S, et al. Effect of vitamin E administered to men in infertile couples on sperm and assisted reproduction outcomes: a double-blind randomized study. F S Rep 2020;1:219-26.